Search research articles
Contact Us
Filters
Showing results (131-140 of 148) with videos related to
Page
of 15
Sort By:
Frontiers in Oncology
|
June 1, 2022
DHW-221, a Dual PI3K/mTOR Inhibitor, Overcomes Multidrug Resistance by Targeting P-Glycoprotein (P-gp/ABCB1) and Akt-Mediated FOXO3a Nuclear Translocation in Non-small Cell Lung Cancer
Mingyue Liu, Chang Xu, Xiaochun Qin, et al.
Therapeutic Advances in Medical Oncology
|
October 8, 2019
Microwave ablation <i>versus</i> resection for hepatocellular carcinoma within the Milan criteria: a propensity-score analysis
Wenwu Liu, Ruhai Zou, Chenwei Wang, et al.
European Journal of Medicinal Chemistry
|
November 28, 2025
Discovery of novel harmine derivatives as potent, selective, and brain permeable GSK3β inhibitors with effective In vivo anti-AD activity
Wenjie Liu, Limeng Wu, Xi Zeng, et al.
Journal of Cancer
|
July 9, 2019
Resection vs Ablation for Multifocal Hepatocellular Carcinomas meeting the Barcelona-Clinic Liver Cancer A Classification: A Propensity Score Matching Study
Wenwu Liu, Zhiwen Yang, Ruhai Zou, et al.
Theranostics
|
May 7, 2020
Dysregulated Sp1/miR-130b-3p/HOXA5 axis contributes to tumor angiogenesis and progression of hepatocellular carcinoma
Yadi Liao, Chenwei Wang, Zhiwen Yang, et al.
Journal of Medicinal Chemistry
|
November 15, 2025
Fluorocyclopropyl-Containing Tacrine Derivatives as Potent and Selective Dual CDK2/CDK9 Inhibitors for the Treatment of Colorectal Cancer
Limeng Wu, Wenjie Liu, Xinyue Ning, et al.
European Journal of Medicinal Chemistry
|
September 2, 2022
Development and structure-activity relationship of tacrine derivatives as highly potent CDK2/9 inhibitors for the treatment of cancer
Limeng Wu, Wenjie Liu, Yaoguang Huang, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
March 27, 2021
Elafin promotes tumour metastasis and attenuates the anti-metastatic effects of erlotinib via binding to EGFR in hepatocellular carcinoma
Chenwei Wang, Yadi Liao, Wei He, et al.
Bioorganic Chemistry
|
March 6, 2025
Discovery and evaluation of novel Benzohydroxamic acid-indole derivatives as dual inhibitors of ADAM17 and HDAC2 with antitumor activity
Xiaoxuan Song, Xin Tong, Kaisi Yang, et al.
Journal of Medicinal Chemistry
|
May 4, 2026
Structure-Based Drug Design to Identify Potent, Selective, and Orally Available Cyclin-Dependent Kinase 9 Inhibitors for the Treatment of Castration-Resistant Prostate Cancer
Wenwu Liu, Limeng Wu, Zhuona Rong, et al.
Page
of 15
Search research articles
Search
Showing results (131-140 of 148) with videos related to
Sort By:
Page
of 15
Frontiers in Oncology
|
June 1, 2022
DHW-221, a Dual PI3K/mTOR Inhibitor, Overcomes Multidrug Resistance by Targeting P-Glycoprotein (P-gp/ABCB1) and Akt-Mediated FOXO3a Nuclear Translocation in Non-small Cell Lung Cancer
Mingyue Liu, Chang Xu, Xiaochun Qin, et al.
Therapeutic Advances in Medical Oncology
|
October 8, 2019
Microwave ablation <i>versus</i> resection for hepatocellular carcinoma within the Milan criteria: a propensity-score analysis
Wenwu Liu, Ruhai Zou, Chenwei Wang, et al.
European Journal of Medicinal Chemistry
|
November 28, 2025
Discovery of novel harmine derivatives as potent, selective, and brain permeable GSK3β inhibitors with effective In vivo anti-AD activity
Wenjie Liu, Limeng Wu, Xi Zeng, et al.
Journal of Cancer
|
July 9, 2019
Resection vs Ablation for Multifocal Hepatocellular Carcinomas meeting the Barcelona-Clinic Liver Cancer A Classification: A Propensity Score Matching Study
Wenwu Liu, Zhiwen Yang, Ruhai Zou, et al.
Theranostics
|
May 7, 2020
Dysregulated Sp1/miR-130b-3p/HOXA5 axis contributes to tumor angiogenesis and progression of hepatocellular carcinoma
Yadi Liao, Chenwei Wang, Zhiwen Yang, et al.
Journal of Medicinal Chemistry
|
November 15, 2025
Fluorocyclopropyl-Containing Tacrine Derivatives as Potent and Selective Dual CDK2/CDK9 Inhibitors for the Treatment of Colorectal Cancer
Limeng Wu, Wenjie Liu, Xinyue Ning, et al.
European Journal of Medicinal Chemistry
|
September 2, 2022
Development and structure-activity relationship of tacrine derivatives as highly potent CDK2/9 inhibitors for the treatment of cancer
Limeng Wu, Wenjie Liu, Yaoguang Huang, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
March 27, 2021
Elafin promotes tumour metastasis and attenuates the anti-metastatic effects of erlotinib via binding to EGFR in hepatocellular carcinoma
Chenwei Wang, Yadi Liao, Wei He, et al.
Bioorganic Chemistry
|
March 6, 2025
Discovery and evaluation of novel Benzohydroxamic acid-indole derivatives as dual inhibitors of ADAM17 and HDAC2 with antitumor activity
Xiaoxuan Song, Xin Tong, Kaisi Yang, et al.
Journal of Medicinal Chemistry
|
May 4, 2026
Structure-Based Drug Design to Identify Potent, Selective, and Orally Available Cyclin-Dependent Kinase 9 Inhibitors for the Treatment of Castration-Resistant Prostate Cancer
Wenwu Liu, Limeng Wu, Zhuona Rong, et al.
Page
of 15